Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
Subjects receiving LEV as adjunctive therapy to 1 or 2 other AEDs for partial onset seizures
and subjects who are temporarily unable to take oral LEV, may require alternative routes of
administration. The purpose of this trial was to evaluate the safety and tolerability of 1000
to 3000 mg/day LEV administered as a 15-min IV infusion b.i.d. after switching from the same
oral dose.